Trial Profile
Clinical Trials Insight: 700044035
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 06 May 2009
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary)
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- Sponsors Sunovion Pharmaceuticals
- 04 May 2009 New trial record.